ARTICLE
14 August 2024

Application Fee For Scientific Meetings Of Pharmaceuticals And Medical Devices Has Been Introduced

G+
Gun + Partners

Contributor

Gün + Partners is a full-service institutional law firm with a strategic international vision, providing transactional, advisory and dispute resolution services since 1986. The Firm is based in Istanbul, with working offices Ankara and Izmir. The Firm advises in life sciences, energy, construction & real estate, technology, media and telecoms, automotive, FMCG, chemicals and the defence industries.”
The Agency first announced on its official website on 4 January 2024, that the Guidelines on Scientific Meetings and Educational Activities to be Conducted within the Scope of the Regulation...
Turkey Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The Agency first announced on its official website on 4 January 2024, that the Guidelines on Scientific Meetings and Educational Activities to be Conducted within the Scope of the Regulation on the Sales, Advertisement and Promotion of Medical Devices (“Guidelines”) was amended, and that the most significant change introduced by the amendment to the Guideline is the collection of fees by the Agency for scientific meetings and applications for educational activities. According to this amendment, it will not be possible to refund the payments made to the Agency for scientific meetings or educational activities applications that are subsequently canceled. In this context, the application fee for scientific meetings and educational activities notifications applications to be made has been set as TRY 1,114.02 (approximately EUR 34) in the 2024 Price Tariff of the Agency. Within the scope of the amendment, no distinction is made between web-based meetings and physical meetings in terms of the payment of the application fee.

Subsequently, the Agency made an addition to the 2024 Fee Tariff and then announced on its website on 18.01.2024 that a service fee would be charged for "Human Medicinal Product Scientific Meeting Support Application", "Human Medicinal Product Promotion Meeting Application" and "Human Medicinal Product Press Announcement Application".

The fact that the application fee regulation is made through guidelines and announcements raises questions about the soundness of the legal basis of the relevant regulation in terms of administrative law. Also, considering that the main motivation of the Agency making amendments to the Regulation and the Guidelines is to facilitate notifications for scientific meetings and educational activities, to increase the number of notifications and to ensure transparency in the activities of the industry, the amendment to introduce an application fee may have the opposite effect by imposing a financial burden on companies or may lead to a decrease in number of the promotional activities.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More